Q3: 2026-05-06 Earnings Abstract
EPS of $0.53 misses by $0.00
| Income of $311.42M (-1.51% Y/Y) misses by $4.64M
Bio-Techne Company (TECH) Financial institution of America World Healthcare Convention 2026 Might 12, 2026 12:20 PM EDT
Firm Contributors
Kim Kelderman – CEO, President & Director
James Hippel – Government VP of Finance & CFO
Convention Name Contributors
Michael Ryskin – BofA Securities, Analysis Division
Presentation
Michael Ryskin
BofA Securities, Analysis Division
My identify is Mike Ryskin. I am on the Financial institution of America Life Science Instruments and Diagnostics staff, and we’re excited to be joined by Bio-Techne. We’re happy to host Kim Kelderman, Chief Government Officer; and Jim Hippel, Chief Monetary Officer. Kim, Jim, thanks for being right here.
Kim Kelderman
CEO, President & Director
Nice. Thanks for having us.
Query-and-Reply Session
Michael Ryskin
BofA Securities, Analysis Division
Format shall be a hearth chat, however increase your hand in the event you’ve obtained a burning query. I imply possibly simply to kick issues off, you latterly reported, any highlights from the quarter you need to speak by way of kind of the way it performed out relative to expectations? What was just a little bit higher, what was just a little bit worse?
Kim Kelderman
CEO, President & Director
Sure. So sure, we reported our Q3 and printed adverse 2% progress for the quarter, and that was over a previous 12 months quarter of about 6% progress. A few dynamics in there that we’ll positively double-click on. However in 1 / 4 like that, you all the time need to look again and ask your self, do you’ve got the fitting technique and is it rolling out in the fitting tempo? And there, I have been happy to see that, as you realize, our technique is round having a very broad core that reads on many alternative finish markets, and that offers us the leverage to select particular fast-growing vertical markets the place we are able to construct out full options in particular software areas. And for us, that is cell remedy, it is protein analytics and it is spatial biology.
